How To Use HCPCS Code C9464

HCPCS code C9464 describes the injection of rolapitant, a medication used to prevent nausea and vomiting caused by chemotherapy. This code is specifically used for the administration of 0.5 mg of rolapitant via injection.

1. What is HCPCS C9464?

HCPCS code C9464 is a specific code used to identify the injection of rolapitant, a medication commonly used in cancer treatment to prevent chemotherapy-induced nausea and vomiting. This code is used to indicate the administration of 0.5 mg of rolapitant via injection.

2. Official Description

The official description of HCPCS code C9464 is “Injection, rolapitant, 0.5 mg.” This description accurately reflects the specific procedure being coded.

3. Procedure

1. Prepare the necessary equipment and supplies for the injection.
2. Verify the patient’s identity and confirm the correct medication and dosage.
3. Select an appropriate injection site, ensuring proper aseptic technique.
4. Administer the rolapitant injection using the appropriate needle and syringe.
5. Monitor the patient for any adverse reactions or complications.

4. When to use HCPCS code C9464

HCPCS code C9464 should be used when documenting the administration of 0.5 mg of rolapitant via injection. This code is specifically for the injection of rolapitant and should not be used for any other medications or procedures.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9464, healthcare providers should ensure that the documentation includes the following:

• Patient’s identification information
• Date and time of the injection
• Description of the procedure performed
• Dosage and administration route (0.5 mg via injection)
• Any relevant supporting documentation, such as medical necessity or prior authorization

6. Historical Information and Code Maintenance

HCPCS code C9464 was added to the Healthcare Common Procedure Coding System on January 1, 1985. It has been terminated since December 31, 2018. The termination of this code means that it is no longer valid for billing purposes. Providers should use the appropriate current code for the administration of rolapitant.

7. Medicare and Insurance Coverage

Medicare and other insurance providers may have specific coverage instructions and pricing indicators for HCPCS code C9464. It is important for healthcare providers to review the coverage policies of each individual payer to determine if reimbursement is available for this specific code.

8. Examples

Here are five examples of when HCPCS code C9464 should be billed:

1. A patient with a history of chemotherapy is receiving their first dose of rolapitant via injection to prevent nausea and vomiting.
2. A cancer patient is undergoing a chemotherapy session and requires the administration of rolapitant via injection to manage potential side effects.
3. A healthcare provider is administering rolapitant via injection to a patient who is scheduled to undergo a chemotherapy treatment later in the day.
4. A patient with a known sensitivity to oral medications is receiving rolapitant via injection as an alternative method of administration.
5. A healthcare provider is administering rolapitant via injection to a patient who has experienced severe nausea and vomiting during previous chemotherapy treatments.